Related Experiment Video
Updated: Aug 7, 2026
10:50
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
Formulation and delivery issues for monoclonal antibody therapeutics
Ann L Daugherty1, Randall J Mrsny
1Genentech, Inc., 1 DNA Way South San Francisco, CA 94080, USA. masi@gene.com
Advanced Drug Delivery Reviews
|July 15, 2006
Summary
Antibody therapies offer high specificity but require large doses. Advances enable large-scale production of monoclonal antibodies, yet formulation stability remains a key challenge for these biopharmaceuticals.
Area of Science:
- Biopharmaceutical development
- Protein engineering
- Drug formulation science
Background:
- Antibodies provide highly specific target recognition for therapeutic applications.
- Large doses of antibodies are often necessary for treating chronic conditions.
- Advances in production and purification enable large-scale manufacturing of monoclonal antibodies.
Purpose of the Study:
- To review challenges in formulating stable antibody-based therapeutics.
- To highlight the importance of formulation for antibody stability and efficacy.
Main Methods:
- Literature review of antibody production, engineering, and formulation.
- Analysis of technical challenges in maintaining antibody stability.
- Discussion of methods for identifying and verifying stable antibody formulations.
Main Results:
- Significant progress in antibody production and genetic engineering has been achieved.
- High concentrations of antibody-based drugs present formulation stability challenges.
- Ensuring stability across various configurations is critical for therapeutic success.
Conclusions:
- Antibody-based therapies are a major focus in pharmaceutical pipelines.
- Formulation development is essential to overcome stability issues in antibody therapeutics.
- Verifying stable antibody formulations is crucial for clinical application.
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.